Cytomegalovirus polyradiculopathy of late onset in a young renal transplant recipient

Clinical Nephrology

Volumn 80, Issue 1, 2013, Pages 75-78

  Papasotiriou, Marios ^a   Papachristou, Evangelos ^a   Marangos, Markos ^a   Koukoulaki, Maria ^a   Savvidaki, Eirini ^a   Kalliakman, Pantelitsa ^a   Goumenos, Dimitrios S ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Cytomegalovirus polyradiculopathy; Renal transplantation

Indexed keywords

BASILIXIMAB; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VALGANCICLOVIR; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CATHETER REMOVAL; CEREBROSPINAL FLUID EXAMINATION; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FATIGUE; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIMB WEAKNESS; LUMBAR SPINAL CORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PNEUMOCYSTIS JIROVECI; POLYMERASE CHAIN REACTION; RADICULOPATHY; SURGICAL INFECTION; THORACIC SPINAL CORD; URETHRAL CATHETERIZATION; URINARY CATHETER; URINE RETENTION;

ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FOSCARNET; GANCICLOVIR; HUMANS; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; POLYRADICULOPATHY; TIME FACTORS;

EID: 84880681454     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107479     Document Type: Article

References (11)

1. Humar A, Limaye A P, Blumberg EA, Hauser IA, Vincenti F , Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P . Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomega-lovirus disease: two-year results of the IMPACT study. Transplantation. 2010; 90: 1427-1431. doi:10.1097/TP.0b013e3181ff1493
2. Zeiser R, Grüllich C, Bertz H, Pantazis G, Hufert FT, Bley TA , Finke J. Late cytomegalovirus poly-radiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004; 33: 243-245. doi:10.1038/sj.bmt.1704311 PubMed
3. Boudreault AA, Xie H, Rakita RM, Scott JD, Davis CL, Boeckh M, Limaye A P. Risk factors for late-onset cytomegalovirus disease in donor sero-positive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis. Transpl Infect Dis. 2011; 13: 244-249. doi:10.1 11 1/j.1399-3062.2011.00624.x
4. Brennan DC, Garlock KA, Singer GG, Schnitzler MA, Lippmann BJ, Buller RS, Gaudreault-Keener M, Lowell JA, Shenoy S, Howard TK, Storch GA.Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation. 1997; 64: 1843-1846. doi:10.1097/00007890-199712 270- 00036
5. Humar A, Siegal D, Moussa G, Kumar D. A prospective assessment of valganciclovir for the treatment of cytomegalovirus infection and disease in transplant recipients. J Infect Dis. 2005; 192: 1154-1157. doi:10.1086/444398
6. Silva CA, Oliveira AC, Vilas-Boas L, Fink MC, Pannuti CS, Vidal JE. Neurologic cytomegalovi-rus complications in patients with AIDS: retrospective review of 13 cases and review of the literature. Rev Inst Med Trop Sao Paulo. 2010; 52: 305-310.
7. Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis. 1993; 17: 32-37. doi:10.1093/clinids/17.1.32
8. Whiteman ML, Dandapani BK, Shebert R T, Post MJ. MRI of AIDS-related polyradiculomyelitis. J Comput Assist Tomogr. 1994; 18: 7-11. doi:10.1 097/00004728-199401000-00002
9. Anders HJ, Goebel FD. Cytomegalovirus polyra-diculopathy in patients with AIDS. Clin Infect Dis. 1998; 27: 345-352. doi:10.1086/514663
10. Caring for Australians with Renal Impairment (CARI). The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients. Nephrology (Carlton). 2004; 9: 37-40. doi:10.1111/j.1440- 17 97.2004.00309.x
11. Kanter J, Pallardó L, Gavela E, Escudero V , Beltrán S, Morales A, Avila A, Crespo J F . Cytomegalovirus infection renal transplant recipients: risk factors and outcome. Transplant Proc. 2009; 41: 2156-2158. doi:10.1016/j.transproceed.2009. 06.0 57